Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets.

Cavallari I, Cerciello F, Giovannetti E, Urso L

Open source

DOI
10.3389/fonc.2023.1163144
Published
2023
Container
Frontiers in oncology
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2023.1163144,
  title = {Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets.},
  author = {Cavallari I and Cerciello F and Giovannetti E and Urso L},
  year = {2023},
  journal = {Frontiers in oncology},
  doi = {10.3389/fonc.2023.1163144},
  url = {https://doi.org/10.3389/fonc.2023.1163144}
}

RIS

TY  - JOUR
TI  - Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets.
AU  - Cavallari I
AU  - Cerciello F
AU  - Giovannetti E
AU  - Urso L
PY  - 2023
JO  - Frontiers in oncology
DO  - 10.3389/fonc.2023.1163144
UR  - https://doi.org/10.3389/fonc.2023.1163144
ER  - 

APA

I, C., F, C., E, G., & L, U. (2023). Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets.. Frontiers in oncology. https://doi.org/10.3389/fonc.2023.1163144

Source records